NCT00266279 2020-09-03
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
University of Louisville
Phase 2 Completed
University of Louisville
University of Miami
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Sanofi